abstract |
A novel arabinomycolate compound useful as an agent for treating or preventing cancer is provided. Equation (1): [Wherein n represents 0 or 1, and R 1 , R 2 , R 14 , R 15 , R 3 , R 4 , R 5 and R 6 independently represent a hydrogen atom, etc.] An arabinomycolate compound or a pharmaceutically acceptable salt thereof having at least one mycoloyl group is used. [Selection figure] None |